Musculoskeletal Cell Therapy
During the last 10 years, we have worked on the development of a somatic cell therapy in the field of muscle regeneration. So far, we successfully demonstrated the effect and safety of an allogeneic cell therapy approach in 20 patients in a Phase I/II study. This allogenic cell therapy is now further tested in a multi-centre Phase III trial to determine its efficacy, safety and tolerability in 240 patients. It is worldwide the first trial of its kind to treat muscle injuries.